Browsing Tag
Fisher & Paykel Healthcare
2 posts
Fisher & Paykel Healthcare (ASX: FPH) tops gainers as FY26 result lands and tariff refund opens
Fisher & Paykel Healthcare just beat. The harder question is whether a US Supreme Court tariff ruling hands FPH a refund or another year of uncertainty.
CSL (ASX: CSL) crashes 17.7% to A$98.59 after FY26 guidance cut and $5bn impairments
CSL cut FY26 NPATA to US$3.1 billion and flagged US$5 billion in impairments. The third downgrade in ten months is repricing the entire ASX healthcare sector.